These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16105632)

  • 1. The difficult task of evaluating how to monitor patients with heart failure.
    Tang WH; Francis GS
    J Card Fail; 2005 Aug; 11(6):422-4. PubMed ID: 16105632
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between B-type natriuretic peptide and health status in patients with heart failure.
    Luther SA; McCullough PA; Havranek EP; Rumsfeld JS; Jones PG; Heidenreich PA; Peterson ED; Rathore SS; Krumholz HM; Weintraub WS; Spertus JA; Masoudi FA;
    J Card Fail; 2005 Aug; 11(6):414-21. PubMed ID: 16105631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and B-type natriuretic peptide levels in heart failure.
    Dolgin M
    J Am Coll Cardiol; 2005 Mar; 45(6):967; author reply 967. PubMed ID: 15766845
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of acute heart failure associated with Guillain-Barré syndrome.
    Palazzuoli A; Lenzi C; Iovine F; Carrera A; Nuti R
    Neurol Sci; 2006 Feb; 26(6):447-50. PubMed ID: 16601940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of natriuretic peptides in heart failure].
    Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R
    Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.
    Lechner E; Schreier-Lechner EM; Hofer A; Gitter R; Mair R; Biebl A; Tulzer G
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):560-4. PubMed ID: 19698835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A difficult diagnosis: right unilateral cardiogenic pulmonary edema. Usefulness of biochemical markers of heart failure for the correct diagnosis.
    D'Aloia A; Faggiano P; Brentana L; Boldini A; Procopio R; Racheli M; Dei Cas L
    Ital Heart J; 2005 Sep; 6(9):771-4. PubMed ID: 16212082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; ;
    Clin Biochem; 2008 Mar; 41(4-5):222-6. PubMed ID: 18035345
    [No Abstract]   [Full Text] [Related]  

  • 10. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 11. Biomarker screening for cardiac dysfunction: the more the merrier?
    Tang WH
    Am Heart J; 2006 Jul; 152(1):1-3. PubMed ID: 16824825
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
    Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.
    Law YM; Ettedgui J; Beerman L; Maisel A; Tofovic S
    Am J Cardiol; 2006 Aug; 98(4):520-4. PubMed ID: 16893709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
    Lindstedt G
    Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic heart failure.
    Cameron P; Krum H
    Emerg Med Australas; 2005 Apr; 17(2):99-101. PubMed ID: 15796721
    [No Abstract]   [Full Text] [Related]  

  • 17. Heart failure: a state of brain natriuretic peptide deficiency or resistance or both!
    Chen HH
    J Am Coll Cardiol; 2007 Mar; 49(10):1089-91. PubMed ID: 17349889
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
    Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of N-terminal proB-type natriuretic peptide.
    Costello-Boerrigter LC; Burnett JC
    Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):194-201. PubMed ID: 16265483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.